ARWR - Arrowhead stock slides 6% as fiscal Q1 report falls short of estimates
2024-02-06 16:57:07 ET
More on Arrowhead Pharmaceuticals
- Arrowhead Pharmaceuticals: A Leading Small-Cap Developer Of RNAi Therapy
- Arrowhead Pharmaceuticals: Transition To Commercialization
- Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be Addressed
- Arrowhead Pharmaceuticals Q1 2024 Earnings Preview
- Arrowhead Pharmaceuticals Q4 2023 Earnings Preview